Health Sciences Acquisitions Co. 2 (HSAQ) Stock Price, News & Analysis

Company Overview

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.

Key Stats

• Today's Range: $3.10 to $3.22
• 50-Day Range: $2.42 to $3.34
• 52-Week Range: $9.41 to $13.80
• Volume: 113,375 shs
• Average Volume: 205,918 shs
• Market Capitalization: $35.43 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HSAQ Stock Analysis - Frequently Asked Questions

How have HSAQ shares performed this year?

Health Sciences Acquisitions Co. 2's stock was trading at $4.00 at the start of the year. Since then, HSAQ stock has decreased by 21.0% and is now trading at $3.16.
View the best growth stocks for 2025 here.

When did Health Sciences Acquisitions Co. 2 IPO?

Health Sciences Acquisitions Co. 2 (HSAQ) raised $139 million in an IPO on Tuesday, August 4th 2020. The company issued 13,900,000 shares at a price of $10.00 per share. Chardan and Barclays acted as the underwriters for the IPO.

How do I buy shares of Health Sciences Acquisitions Co. 2?

Shares of HSAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Health Sciences Acquisitions Co. 2 own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Health Sciences Acquisitions Co. 2 investors own include Churchill Capital Corp IV (CCIV), FS Development (FSDC), Gores Holdings IV (GHIV), Gores Holdings V (GRSVU), Holicity (HOLUU), Kismet Acquisition One (KSMTU) and Lionheart Acquisition Co. II (LCAPU).

Company Calendar

• Today: 6/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:HSAQ
• CIK: 1814114
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$380 thousand
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -2.38%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.17
• Quick Ratio: 0.61

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.62) per share
• Price / Book: -5.10

Miscellaneous

• Outstanding Shares: 11,212,000
• Free Float: 8,757,000
• Market Cap: $35.43 million
• Optionable: Not Optionable
• Beta: 0.09